Transdermal Drug Delivery Market Analysis 2022: Technological Advances Present Lucrative Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transdermal Drug Delivery Market Analysis by Applications, by Type, by End user, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The transdermal drug delivery market size is estimated to be USD 6.5 billion in 2021 and is expected to witness a CAGR of 6.23% during the forecast period 2022-2029. The rising incidence of chronic diseases and technological improvements in transdermal medication delivery methods are expected to boost the market. Additionally, initiatives by government organizations contributing to the market growth. However, drug failure is expected to hinder the growth.

Segmentation: Transdermal Drug Delivery Market Report 2021-2029

By Application (Revenue, USD Billion)

• Hormonal Applications
• Central Nervous System Disorders
• Pain Management
• Cardiovascular Diseases
• Others

By Type (Revenue, USD Billion)

• Transdermal Semisolids
• Transdermal Patches

By End user (Revenue, USD Billion)

• Hospitals & Clinics
• Home Care Settings

By Region (Revenue, USD Billion)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Transdermal Drug Delivery

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Transdermal Drug Delivery Market

7. Market Analysis by Application

8. Market Analysis by Type

9. Market Analysis by End user

10. Regional Market Analysis

11. North America Transdermal Drug Delivery Market

12. Europe Transdermal Drug Delivery Market

13. Asia Pacific Transdermal Drug Delivery Market

14. Latin America Transdermal Drug Delivery Market

15. MEA Transdermal Drug Delivery Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion & Recommendations

Companies Mentioned

• Hisamitsu Pharmaceutical (Japan)
• Mylan (US)
• UCB (Belgium)
• Novartis (Switzerland)
• GlaxoSmithKline (UK)
• Boehringer Ingelheim (Germany)
• Johnson & Johnson (US)
• Endo International (Ireland)
• Purdue Pharma (US).

For more information about this report visit https://www.researchandmarkets.com/r/x8fqla

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900